A rare cause of cavitatory pneumonia

N S Harsha1, H S Sandeepa2, S Hemantha Kumar1

  • 1Dept of Internal Medicine, People Tree Hospitals, Bengaluru, India.

Insights

Escherichia coli pneumonia rarely causes lung cavities. This case highlights E. coli as a cause of bilateral necrotizing pneumonia with cavities in a diabetic patient.

Area of Science:

  • Pulmonary Medicine
  • Infectious Diseases
  • Radiology

Background:

  • Thick-walled lung cavities on radiography suggest infections like tuberculosis, fungi, or vasculitis.
  • Necrotizing pneumonia from Gram-negative bacteria (e.g., Klebsiella, Pseudomonas) or Staphylococcus aureus can also cause cavities.
  • Escherichia coli pneumonia leading to pulmonary cavities is exceptionally rare, typically presenting as pneumatoceles.

Observation:

  • A 67-year-old male with uncontrolled type 2 diabetes mellitus presented with symptoms suggestive of pneumonia.
  • Radiographic imaging revealed bilateral, thick-walled cavities in the lungs with consolidation.
  • Diagnostic workup identified Escherichia coli as the causative pathogen.

Findings:

  • The patient was diagnosed with bilateral cavitating necrotizing pneumonia.
  • This case represents a rare instance of Escherichia coli causing extensive lung destruction and cavity formation.
  • Uncontrolled diabetes mellitus was a significant comorbidity, potentially predisposing the patient to severe infection.

Implications:

  • This case expands the differential diagnosis for cavitating lung lesions, particularly in immunocompromised patients.
  • It underscores the potential for unusual bacterial pathogens, like E. coli, to cause severe pulmonary disease.
  • Clinicians should consider a broad range of pathogens, including E. coli, in patients with necrotizing pneumonia and lung cavities, especially those with diabetes.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.2K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.8K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.1K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
999
Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
5.2K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.9K